3.0.0 1930 2023-01-15T09:03:29Z 2023-01-15T09:03:29Z Senate S S 2003-11-21 108 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2003-11-22T00:51:23Z RU-486 Suspension and Review Act of 2003 108 3453 HR 2003-11-14 Referred to the Subcommittee on Health. Related bill CRS 2003-11-21 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2003-11-21 Sponsor introductory remarks on measure. (CR S15473-15475) IntroReferral B00100 9 Library of Congress 2003-11-21 Introduced in Senate IntroReferral 10000 9 Library of Congress B000953 Sen. Brownback, Sam [R-KS] SAM BROWNBACK R KS N E000194 Sen. Ensign, John [R-NV] JOHN ENSIGN R NV 2003-11-21 True E000285 Sen. Enzi, Michael B. [R-WY] MICHAEL ENZI R WY B. 2003-11-21 True H001028 Sen. Hagel, Chuck [R-NE] CHUCK HAGEL R NE 2003-11-21 True I000024 Sen. Inhofe, James M. [R-OK] Jim Inhofe R OK 2003-11-21 True N000102 Sen. Nickles, Don [R-OK] DONALD NICKLES R OK LEE 2003-11-21 True S000059 Sen. Santorum, Rick [R-PA] RICK SANTORUM R PA 2003-11-21 True S001141 Sen. Sessions, Jeff [R-AL] Jeff Sessions R AL 2003-11-21 True B001066 Sen. Bunning, Jim [R-KY] JIM BUNNING R KY 2004-01-22 False Health Abortion Administrative procedure Commerce Congress Congressional investigations Congressional reporting requirements Congressional veto Department of Health and Human Services Drug approvals Drugs Food and Drug Administration (FDA) Government Operations and Politics Government publicity Labeling Law Health 00 2003-11-21 Introduced in Senate 2003-12-12T20:03:56Z RU-486 Suspension and Review Act of 2003 - Deems the approved application for the drug mifepristone (marketed as Mifeprex, commonly known as RU-486, and used for the chemically induced termination of intrauterine pregnancy) to have been suspended.

Directs the Comptroller General to review and report on the process by which the Food and Drug Administration (FDA) approved mifepristone. Provides for the contingent reinstatement of such drug if the report determines the approval to have been in accordance with the Federal Food, Drug, and Cosmetic Act.

]]> RU-486 Suspension and Review Act of 2003 Display Title RU-486 Suspension and Review Act of 2003 Official Title as Introduced A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug commonly known as RU-486 is deemed to have been withdrawn, to provide for the review by the Comptroller General of the United States of the process by which the Food and Drug Administration approved such drug, and for other purposes. Introduced in Senate IS Short Titles as Introduced RU-486 Suspension and Review Act of 2003 Introduced in Senate 2003-11-21T05:00:00Z 2003-11-21 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.